Suppr超能文献

ε-氨基己酸对特发性脊柱侧弯患者后路脊柱融合术围手术期失血的影响:一项初步前瞻性研究。

The Effect of epsilon-aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion: a preliminary prospective study.

作者信息

Florentino-Pineda I, Blakemore L C, Thompson G H, Poe-Kochert C, Adler P, Tripi P

机构信息

Division of Pediatric Orthopaedics, Rainbow Babies and Children's Hospital, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio, USA.

出版信息

Spine (Phila Pa 1976). 2001 May 15;26(10):1147-51. doi: 10.1097/00007632-200105150-00011.

Abstract

STUDY DESIGN

A prospective study evaluating the efficacy of epsilon-aminocaproic acid (EACA) in decreasing perioperative blood loss in idiopathic scoliosis.

OBJECTIVES

To compare the perioperative blood loss and need for blood replacement in two groups of patients undergoing surgery for idiopathic scoliosis. One group received intraoperative EACA; the other did not and served as controls.

SUMMARY OF BACKGROUND DATA

Excessive blood loss increases the operative time, risk for blood product disease transmission, postoperative complications, and costs associated with posterior spinal fusion and instrumentation. EACA is an antifibrinolytic agent that has been shown to be effective in reducing perioperative blood loss during pediatric cardiothoracic surgical procedures. We hypothesized that it would also be effective in lowering blood loss during posterior spinal fusion for idiopathic scoliosis.

METHODS

We compared the perioperative blood loss of 28 consecutive pediatric patients with idiopathic scoliosis who underwent posterior spinal fusion and received intraoperative EACA with 31 consecutive patients who did not receive this medication and served as a control group.

RESULTS

The patients in both groups were similar. Patients in the EACA group demonstrated statistically significant decreases in total estimated perioperative blood loss and the need for autologous blood transfusion. The patients in the EACA group had no intraoperative or postoperative complications related to the use of this medication.

CONCLUSIONS

Based on these preliminary findings, we believe that EACA is helpful in decreasing blood loss in patients undergoing posterior spinal fusion and instrumentation, and may decrease the number of autologous units needed to maintain safe perioperative hemoglobin levels, thereby improving safety and lowering cost associated with scoliosis surgery.

摘要

研究设计

一项前瞻性研究,评估ε-氨基己酸(EACA)在减少特发性脊柱侧凸围手术期失血方面的疗效。

目的

比较两组接受特发性脊柱侧凸手术患者的围手术期失血量及输血需求。一组术中接受EACA;另一组未接受,作为对照组。

背景数据总结

失血过多会增加手术时间、血液制品疾病传播风险、术后并发症以及与后路脊柱融合和内固定相关的费用。EACA是一种抗纤维蛋白溶解剂,已被证明在小儿心胸外科手术中可有效减少围手术期失血。我们假设它在特发性脊柱侧凸后路脊柱融合术中减少失血也有效。

方法

我们比较了28例连续接受后路脊柱融合并术中接受EACA的特发性脊柱侧凸小儿患者与31例未接受该药物作为对照组的连续患者的围手术期失血量。

结果

两组患者情况相似。EACA组患者在估计的围手术期总失血量和自体输血需求方面有统计学意义的显著降低。EACA组患者未出现与使用该药物相关的术中或术后并发症。

结论

基于这些初步发现,我们认为EACA有助于减少接受后路脊柱融合和内固定患者的失血,并可能减少维持围手术期安全血红蛋白水平所需的自体血单位数量,从而提高安全性并降低与脊柱侧凸手术相关的成本。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验